Form 4: Crexendo Chief Technology Officer Executes Stock Option and Sells Shares
SEC Form 4 Filing
Crexendo's Chief Technology Officer, David Tzat-kin Wang, exercised stock options and sold shares on December 10th and 11th, 2024.
Summary
- David Tzat-kin Wang, Chief Technology Officer of Crexendo, Inc., engaged in transactions involving the company's stock on December 10th and 11th, 2024.
- On December 10th, Wang exercised options to acquire 6,000 shares of common stock at a price of $0.91 per share and then sold those 6,000 shares at a weighted average price of $5.1542 per share.
- On December 11th, Wang exercised options to acquire 1,707 shares of common stock at a price of $0.91 per share and then sold those 1,707 shares at a weighted average price of $5.1542 per share.
- Following these transactions, Wang's direct ownership of common stock decreased from 449,079 to 443,079 shares.
- Wang also holds 746,246 non-qualified stock options after the transactions.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of insider trading activity. It is neither particularly positive nor negative, but rather a neutral reporting of transactions.
Positives
- The exercise of stock options indicates that the executive believes in the company's future prospects.
- The sale of shares at a higher price than the exercise price demonstrates a potential profit for the executive.
Negatives
- The sale of shares by a key executive could be perceived negatively by some investors.
Risks
- Executive stock sales can sometimes signal a lack of confidence in the company's future performance, although this is not always the case.
- The market may react negatively to the sale of shares by a key executive.
Industry Context
This is a standard Form 4 filing, which is common for publicly traded companies when insiders engage in transactions involving their company's stock. It is a routine disclosure required by the SEC.
Comparison to Industry Standards
- Form 4 filings are a standard practice for all publicly traded companies in the US, and this filing is consistent with those requirements.
- The transactions are typical for executives who receive stock options as part of their compensation package.
- The sale of shares after exercising options is a common practice for executives to realize gains.
Stakeholder Impact
- Shareholders may be interested in the transactions of company insiders as it can provide insights into management's view of the company's prospects.
- The sale of shares by an executive could potentially impact the stock price, although the impact is likely to be minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 06/01/2021 | Date the non-qualified stock options became exercisable. |
| 12/10/2024 | Date of the first set of stock option exercises and sales. |
| 12/11/2024 | Date of the second set of stock option exercises and sales. |
| 12/12/2024 | Date the Form 4 was signed. |
| 03/11/2026 | Expiration date of the non-qualified stock options. |
Keywords
Crexendo, CXDO, stock options, insider trading, David Tzat-kin Wang, Chief Technology Officer, stock sale, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.